Novavax to Participate in Jefferies London Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Buy Rating Reaffirmed for Springworks Therapeutics Amid Promising Outlook for Ogsiveo and Mirdametinib
In a report released yesterday, Alec Stranahan from Bank of America Securities reiterated a Buy rating on Springworks Therapeutics (SWTX ...
The Globe and Mail12m
S&P Futures Tick Lower as Key U.S. Inflation Data Looms
December S&P 500 E-Mini futures (ESZ24) are trending down -0.19% this morning as investors held back from making big bets ahead of a crucial U.S. inflation report that could influence the Federal ...
kffhealthnews3m
STI Infections Are Slowing; Health Experts Call For Cautious Optimism
She said initial symptoms included conjunctivitis, fever, and cough. (Schnirring, 11/12) Novavax yesterday announced that the US Food and Drug Administration (FDA) has released a clinical hold on its ...
Le Lézard48m
Catheter Precision, Inc. Announces Third Quarter Update and Financial Results
Global Clingwrap Machine Market was... Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that it will participate in the Jefferies London ...